PATENT CLAIM ANALYSIS

Application Number: 16119887
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["435", "366000"]

Abstract:
The present invention provides methods to promote differentiation of pancreatic endoderm cells to pancreatic endocrine rich clusters and to enhance insulin expression in hormone-expressing cells.

Claim (Index 3):
The method of  claim 1 , wherein the level of expression of insulin, glucagon, and ghrelin is not affected in pancreatic endoderm cells treated with medium comprising semaphorin 3a or Epigen as compared to pancreatic endoderm cells not treated with medium comprising semaphorin 3a or Epigen.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 96.0
- Lexical Diversity: 1.18182
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15340418', '16119862', '13911829', '13708369', '13998883']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6645919130170675
- 35 USC 102 Novelty (BERT): 0.6069119305029611
- Combined Prediction Score: 0.6588239147656569
- Mean Citation Score: 578.6506139999998
- Max Citation Score: 644.7586
- Similarity Product: 473.2362663326024

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test